Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression

Impact of Sofosbuvir and Daclatasvir therapy on the expression levels of inflammasomes in chronic hepatitis C infected patients

Study the Effect of Sofosbuvir, Daclatasvir and Ribavirin on Hematologic Profile, ‎Vitamin B12 and Folic Acid Levels in HCV-Related Cirrhotic Patients‎

Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Impact of Sustained Virological Response on ‎Metabolic Changes and Vitamin-D Status in ‎Patients with Hepatitis C Viral Infection Treated by ‎Direct Acting Antiviral drugs

Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin

Studying the Kynurenine, Some Hematological and Biochemical Changes on Egyptian Patients with Chronic Hepatitis C During and After Treatment with Sofosbuvir

Efficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs